Landing Page Devicesv2

Cookies Policy

Use of cookies

A cookie is a small text file which is placed onto your computer (or other electronic device) when you access our website. We use cookies to enable the website to remember information that you previously input. This helps us to improve the performance of our website for our users by providing content-specific information by tracking how sections of our website are used. We may also use cookies to obtain information for undertaking research and statistical analysis to help improve our content. Cookies allow us to provide you with a better and more efficient user experience, by understanding your preferences and tailoring your access to such preferences.

We do not sell the information we collect from our use of cookies.

Consent

In most cases we will need your consent in order to use cookies on this website.

There is a notice on our home page which describes how we use cookies on this website and which also provides a link to this Cookies Policy. If you use this website after this notification has been displayed to you, we will assume that you consent to our use of cookies for the purposes described in this Cookie Policy and our Privacy Policy. Please note that your consent can be withdrawn at any time, however if you do not consent to cookies being installed on your browser, Sinclair Pharma may not be able to provide you full access to or all the functionality of our websites.

Third-party cookies

We work with third party suppliers who may also set cookies on our website, for example Facebook, Twitter, YouTube, WordPress, Google Analytics, google.com, Mediaplex, doubleclick.net and scorecardresearch.com. These third party suppliers are responsible for the cookies they set on our website. If you want further information please go to the website of the relevant third party.

How to turn off cookies

You can turn off cookies by changing your browser settings to erase cookies from your computer’s hard drive, block all cookies, or receive a warning before a cookie is stored. Please check your Internet browser’s instructions to learn more about these functions.

Please be aware though that you may lose some of the functionality of this website if you do not allow cookies.

To find out more about cookies and how to manage and/or delete them, please visit aboutcookies.org or allaboutcookies.org for further information.

This policy was updated in August 2018.

INDICATION: V-SERIES

Local laws vary regarding the delegation of Radiofrequency (RF), Fractional RF, IPL and long pulse 1064 nm Nd: YAG laser treatments to non-physicians and change over time. Please consult your local regulations.

Like all medical procedures, not all patients are suitable for V-SERIES treatments. The V-SERIES platforms (V10, V20 and V30) are multi-application devices, designed for aesthetic and dermatological procedures. Their clinical performance and safety are related to the handpiece and its technology. The V-SERIES handpieces include V-FC, V-FORM, V-ST, V-FR, V-VR, V-IPL and V-Nd: YAG.

The V-FORM and V-FC handpieces stimulate bi-polar RF energy and negative pressure (vacuum suction). The mechanical action of the vacuum stimulates the skin to increase blood microcirculation and lymphatic drainage while facilitating deeper penetration of RF heat to the dermis and hypodermis. The RF electrical current generates heat in the skin through resistance in the dermis and subcutaneous layers. This volumetric heating of the skin also increases blood microcirculation leading to enhanced natural lipolysis and therefore circumferential reduction.

The V-ST handpiece’s RF electrical current generates heat in the skin through resistance in the dermis and subcutaneous layers. Volumetric heating of the skin increases blood microcirculation, leading to collagen remodelling and skin tightening.

The V-VR Handpiece’s electrical current generates heat in the skin through resistance in the vaginal wall. Volumetric heating of the skin increases blood microcirculation leading to collagen remodelling, resulting vaginal laxity improvement.

The V-FR handpiece stimulatingly delves fractional bi-polar RF energy, contact cooling and negative pressure. RF heating increases the skin temperature to produce pin-point superficial ablation and dermal coagulation, leading to skin resurfacing.

The V-IPL handpiece emits a spectrum of light from a variety of “cut-off” filters (ranging from 415 nm up to 755 nm). The light absorbed by the skin’s target chromophores (light-sensitive molecules: water, melanin, hemoglobin, porphyrin) reacts to the light according to the principle of selective photo-thermolysis, leading to the temperature rise of the selected chromophore and its consequential destruction.

The V-Nd: YAG handpiece delivers light energy at 1064 nm and the skin’s target chromophores (light-sensitive molecules: water, melanin, hemoglobin) react to the light according to the principle of selective photo-thermolysis, leading to the temperature rise of the selected chromophore and its consequential destruction.

The treating practitioners and patients should discuss the V-SERIES procedure and review the risks and benefits of this procedure. Please review more detailed information regarding V-SERIES safety and indications.